NanoViricides, Inc. CEO Releases Details Of “Just In Time’’ Manufacturing; Company To Begin Animal Testing Of New Drugs This Fall

August 30, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 30, 2006--NanoViricides, Inc. (Pink Sheets: NNVC) CEO Dr. Eugene Seymour, MD, MPH, says the company is poised to usher in a new era of "just in time manufacturing" of antiviral medications.

Twitter
LinkedIn
Facebook
Email
Print

Events